Variant transthyretin amyloidosis (A-ATTRv) caused by the p.Val50Met mutation is a multisystemic disease with marked geographic variability. Mallorca represents one of the main endemic foci in Europe. Although disease-modifying therapies have improved prognosis, real-world data on hospitalizat...
The Verdict
ClassificationAI Generated
ConfidenceMedium confidence
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/b6d8f072-5759-46b7-b48f-963fa7dd6bb2)